Ramos B cells are also shown to be sensitive to IFN-α stimulation 32. The cells hence provide an ideal system to study the primary regulation mechanism of IFN-α on IL-4 signals relevant for CD23 gene expression. We have first analyzed the effect of IFN-α on the IL-4-inducible CD23 expression. The flow cytometric data show that IL-4 induced a significant increase (over 4-fold) of cell surface CD23 expression (Fig. Y-27632 ic50 1), and IFN-α inhibited the induction of CD23 expression by IL-4 in a dose-dependent manner (Fig. 1A, right panel). A nearly
complete inhibitory effect of IFN-α on the IL-4-induced CD23 expression is shown in a representative FACS analysis (Fig. 1A, middle panel). The antagonistic effect of IFN-α was confirmed at CD23 mRNA levels measured by quantitative real-time-PCR. As reported for primary B cells 19, 20, the result demonstrates that IFN-α effectively suppresses the IL-4-induced CD23 mRNA expression to reduce cell surface CD23 levels in Ramos B cells, which is a property shared by IFN-γ (Supporting Information Fig. S1-A). It appears that early signals generated by IL-4, through Jak1/STAT6 activation, are capable of leading to CD23 gene expression and sustaining it, since the critical role of STAT6 activation in the IL-4 induction of CD23
expression has been clearly demonstrated by studies with STAT6-deficient models 33. The inhibition Selleckchem GSK2126458 of IFN-α on the IL-4-induced CD23 gene expression, however, exhibited a delayed kinetics, requiring at least 4 h incubation after IFN-α treatment (Fig. 1B). Thus in the experiments followed, we examined mainly
the effect of IFN-α pretreatment for 4 h on the IL-4-induced Jak/STAT6 activation to further investigate stiripentol the inhibitory mechanism of IFN-α on the IL-4 signaling leading to CD23 gene regulation. When the IFN-α-treated Ramos B cells were analyzed for the IL-4-inducible Jak1/3 and STAT6 activities, no appreciable changes were observed on the Jak1/3 phosphorylation and total tyrosine phosphorylation of STAT6 during the periods (up to 4 h) required for the suppression of CD23 gene expression by IFN-α (Fig. 2A). Yet, upon cell fractionation, the effect of IFN-α on the cytosolic retention (+66%) and reduced nuclear localization (−75%) of IL-4-induced pY-STAT6 was evident in cells treated with IFN-α for 4 h, while co-treatment of IFN-α for 0.5 h produced a little effect, showing a pattern of STAT6 phosphorylation and localization similar to the treatment of IL-4 alone (Fig. 2B). Densitometry data obtained from multiple blots demonstrate relative phosphorylation levels of STAT6, shown as pY-STAT6/STAT6 ratio in different cellular fractions (Fig. 2B). We then examined cellular localization of STAT6 using confocal microscopic analysis. The data also show that IFN-α treatment for 4 h resulted in increased cytoplasmic levels of pY-STAT6 with its reduced nuclear localization in B cells (Fig. 2C).
A question remains about the possible source of increased Th17 cells in HT patients. As an important proinflammatory mediator, leptin could stimulate the proliferation of T lymphocytes and promote the Th1 phenotype immune response . Moreover, some recent studies indicate that leptin signalling controls the proliferation of CD4+CD25+ Treg cells through an autocrine pathway, because Treg cells produce higher levels of leptin and express high
leptin receptors www.selleckchem.com/products/INCB18424.html . In agreement with this observation, significantly increased Tregs are found in both the leptin deficiency (ob/ob) and leptin receptor deficiency (db/db) mice; administration with the leptin blockade could delay the onset and progression of EAE, which shows an inverse correlation between the concentration of leptin and the percentage of Treg cells . These
findings provide strong evidence that leptin signalling modulates a balance between effector T cells (Teff) and Treg cells. Because IL-6 plays an important role in regulating the balance between IL-17-producing Th17 cells and Tregs [26, 27] and the leptin signalling pathway shares the selleck chemical highest structural similarity and signalling capability with those of the IL-6-type cytokine receptors , we hypothesized that high levels of leptin may partly modulate Th17 cells involved in the pathogenesis of HT disease. In the present study, we provide direct evidence that plasma leptin and CD4+ T cell-derived leptin were higher in HT patients compared with
healthy controls. Neither the percentage of Th17 cells nor the level of Th17 cell-specific transcription factor RORγt correlated with plasma leptin, but the percentage of Th17 cells or the level of RORγt correlated positively with CD4+ T cell-derived leptin in HT patients. In addition, we have detected up-regulated levels of leptin, IL-17 and RORγt expression in TMCs from HT patients compared to a patient with simple goitre. To address a direct role of leptin in modulating Th17 cells, we found that neutralization of leptin decreases why Th17 cells in vitro. Together, our results provide direct evidence that T cell-derived leptin, but not plasma leptin, may contribute to the pathogenic role of increased Th17 cells in HT patients. Thus, further studies are warranted to characterize the molecular mechanism of leptin-mediated modulation of Th17 cells. This study was supported by National Natural Science Foundation of China (grant no. 30871193, 81072453, 30972748, 31100648, 30910103087), Health Department Foundation of Jiangsu Province (grant no.H200952), Graduate Student Research and Innovation Program of Jiangsu Province (CXLX11_0608, CXZZ12_0710), Jiangsu Province Qinglan Project and Top Talent Program of Jiangsu University. The authors have no financial conflicts of interest.
27. During long-term exposure to the antigen, leading to a chronic lung inflammation, the number of eosinophils and monocytes were significantly upregulated. The lack of Thy-1 resulted in decreased infiltration of eosinophils and monocytes into the lung during acute as well as chronic
inflammation, indicating a key role of Thy-1 Ipatasertib price in airway inflammation induced by OVA. Thus, investigating different inflammation models in Thy-1−/− mice, we could prove the physiological relevance of Thy-1 in the control of the recruitment of leukocytes at sites of inflammation in vivo. Due to strong expression of Thy-1 on TCs in mice, Thy-1 was investigated previously in mouse models with respect to the role of Thy-1 for development and function of TCs 14, 28, 29. Beissert et al. showed that Thy-1 deficiency in mice led to reduced contact hypersensitivity responses and a decreased irritant dermatitis, which were suggested to be due to a defective fine tuning of TC functions 14. In the light of our data, the impaired cutaneous immune responses in Thy-1−/− mice might, in addition to affected TC responses, also be caused by the lack of Thy-1 as an adhesion receptor on EC, mediating
the extravasation of leukocytes during inflammation. Considering the high expression of Thy-1 on murine TCs 29, 14 and the pathogenic role of TCs in OVA-induced lung inflammation 21, we excluded that the reduced lung inflammation in Thy-1−/− mice was dependent of the
different Thy-1 expression levels on TCs. In Thy-1 BM chimera, the Thy-1-expression was detectable on 70% of TCs. Although Thy-1−/− BM learn more chimera expressed Thy-1 on TCs and Thy-1−/− mice did not, airway inflammation was similarly reduced in both. In addition, BM transfer did not result in the incorporation of Thy-1-positive EC progenitor cells into the vessels, as Thy-1 staining of lungs revealed that PIK3C2G vessels did not express Thy-1 in the BM chimeras. Thus, we can conclude that reduced extravasation of eosinophils and monocytes during airway inflammation in Thy-1-deficient mice is independent of Thy-1 expression on TCs and relies on the Thy-1 expression on activated ECs. Gerwin et al. used the approach of generating BM chimera to exclude effects of TCs in an inflammation model in ICAM-2−/− mice. Accordingly, they also showed that the lack of ICAM-2 on ECs was responsible for the decreased eosinophil emigration during lung inflammation 30. As expected, the infiltration of leukocytes to the BAL fluid or into the peritoneal cavity was not completely inhibited in Thy-1−/− mice, suggesting a functional impact of further adhesion molecules. For example, ICAM-1−/− mice showed strongly decreased leukocyte infiltration in an OVA-induced inflammation model 31, as well as in a murine model of toluene diisocyanate-induced lung inflammation 32.
The macrophages were then infected by BCG for 24 hr. We used an LDH assay to analyse the viability of macrophages in the presence of SP600125. The data revealed that there was no significant difference in LDH release among the groups, suggesting that the viabilities of Alvelestat in vivo macrophages among the groups were similar (Fig. 2b). Consistent with previous studies, with the addition of SP600125,
NO production in BCG-infected macrophages was significantly reduced by about 74% when compared with solvent control. The inhibitor also significantly reduced IL-17A-enhanced NO production by about 66% (Fig. 2c). The specificity of SP600125 towards JNK, ERK1/2 and p38 MAPK was also analysed. It was observed that only the BCG-induced phosphorylation of JNK, but not ERK1/2 or p38 MAPK, was inhibited by SP600125 (Fig. 2d, lane 2 versus lane 6; lane 3 versus lane
7). The data suggested ICG-001 datasheet that SP600125 was able to specifically block the activation of JNK. Taken together, we confirmed the involvement of JNK in IL-17A-enhanced NO production in BCG-infected macrophages. The expression of iNOS has been shown to be regulated at the post-transcriptional level via the JNK signalling pathway, which contributes to stabilization of iNOS mRNA. Our data showed that IL-17 was able to enhance BCG-induced phosphorylation of JNK (Fig. 2a). Therefore, we are interested to assess whether IL-17A is able to affect the stability of BCG-induced iNOS mRNA. Using qPCR analysis, our data showed that the half-life of iNOS mRNA in BCG-infected macrophages was about 101 min. In the presence of IL-17A, the half-life of BCG-induce iNOS mRNA was prolonged to about 227 min (Fig. 3). Our results indicated that IL-17A was able to enhance the stability of BCG-induced iNOS mRNA, thereby allowing for increased NO production. Nuclear factor-κB is a key transcription factor that drives the expression of iNOS.[28, 29] The BCG-induced activation of the NF-κB pathway in macrophages
requires degradation of IκBα in the cytoplasm, which allows the release of NF-κB and subsequent translocation many of NF-κB into the nucleus for initiation of gene expression.[19, 30, 31] To investigate whether IL-17A pre-treatment affects BCG-activated NF-κB pathways, we analysed the degradation of IκBα in the cytoplasm and translocation of NF-κB p65 into the nucleus. We pre-treated the macrophages with IL-17A for 24 hr, followed by BCG infection for 15 min. Cytoplasmic proteins and nuclear proteins were extracted for Western blot analysis of IκBα and NF-κB p65, respectively. Our results showed that infection of macrophages by BCG caused degradation of IκBα and also translocation of NF-κB p65 into the nucleus (Fig. 4, lane 2). However, neither process was affected by IL-17A pre-treatment (Fig. 4, lane 3). Our results suggested that IL-17A had no effects on the activation of the NF-κB pathway during BCG infection.
Two basic algorithms used during
applications of smoothing filter include calculation of the so-called ‘Smoothed DB(biggest)’ (filter that reduces the series of box sizes by starting at the smallest box size and going only towards greater sizes than the previous) and ‘Smoothed DB(small)’ (filter that reduces the series of box sizes by starting at the largest size and going only towards smaller box sizes). Although it is expected that smoothed DB(biggest) and smoothed DB(small) are closely correlated with Db, their calculation LY2109761 clinical trial may significantly increase the validity of the obtained Db results (assuming that all three dimensions change in the same way). Lacunarity (Λ) was calculated using the following formula: Grey level co-occurrence https://www.selleckchem.com/products/PD-0325901.html matrix (GLCM) textural analysis of each chromatin structure was performed using ImageJ software and its texture analysis plugins developed by Julio E. Cabrera and updated by Toby C. Cornish.[21, 22] Calculation of GLCM features, angular second moment (ASM) and
inverse difference moment (IDM) was done according to the protocol first presented in the work of Haralick et al.: As an addition to the experimental protocol, we tested the inter-rater reliability of fractal and GLCM analysis methods by determining Pearson’s correlation coefficient for each of the measured parameters. A sample of 100 randomly selected MDC nuclei were segmented and analyzed by two researchers (IP and JP). Values of Pearson correlation coefficient for interobserver agreement were 0.983 for DB, 0.989 for DB(small), 0.983
for DB(biggest), 0.963 for Λ, 0.998 for ASM and 0.994 for IDM. These results suggest that fractal and GLCM analysis are almost exact methods with potentially high reproducibility. Statistical analysis was performed using anova test with Bonferroni confidence level adjustment and Spearman’s rank correlation coefficient in SPSS v 17.0 statistical package (SPSS, Chicago, IL, USA). Average values of DB, smoothed DB(biggest) and smoothed DB(small) are presented in Table 1. In newborn mice, average fractal dimension of MDC nuclear chromatin structure was 1.435 ± 0.017. In 10-day-old animals average DB was 1.406 ± 0.018 and in 20-day-old animals 1.398 ± 0.030. Mice aged 30 days had average DB of 1.380 ± 0.025. Using anova test for independent samples statistically highly significant difference was detected between the groups (F = 7.54, P < 0.001). When post-hoc analysis was applied, it was calculated that fractal dimension in animals aged 10 days, 20 days and 30 days was significantly lower (P < 0.05, P < 0.01 and P < 0.001 respectively, Fig. 2) when compared to the newborn mice (controls). There was no statistically significant difference (P > 0.05) in any other group pairs (10 days vs 20 days; 10 days vs 30 days; 20 days vs 30 days).
Immunization of female CBA mice by infection with live sporozoites of a single strain, CB or AJ, of the malaria parasite P. c. chabaudi, under the cover of the anti-blood-stage antimalarial drug, MF, induced responses that were variously effective before and/or during patent blood infection following challenge with either sporozoites or blood-stage parasites of one or the other of these two strains of parasite. The effects of immunization with live sporozoites under MF cover included strain-specific suppression
of pre-patent IWR-1 chemical structure parasite growth (CB sporozoite-immunization suppressed pre-patent parasite growth in CB sporozoite–induced infections but not in those of AJ sporozoite–induced infections); strain-specific suppression of patent erythrocytic parasite growth (CB sporozoite–immunisation suppressed blood-parasite growth in sporozoite- and blood parasite-induced infections of CB more than it did to
growth of blood parasites in corresponding AJ infections; AJ sporozoite–immunized mice partially suppressed growth of AJ blood parasites in sporozoite- and blood parasite-induced infections but did not suppress growth of CB blood parasites); pan-strain suppression buy Hydroxychloroquine of patent erythrocytic parasite growth (CB sporozoite–immunization suppressed growth of erythrocytic parasites in sporozoite- and blood parasite-induced infections of both AJ and CB). It should also be noted that the parasites showed strain-specificity, or its absence, in their immunological properties not only as targets of immunity but also as inducers of immunity. While both AJ and CB were involved in the induction of strain-specific immunity against the blood-stage parasites, only CB, and not AJ, live sporozoite immunization induced powerful pan-strain effects in suppressing blood-stage parasites. Such strain-specific properties of the induction of immunity against blood-stage parasites Histamine H2 receptor have been recorded previously among strains of P. c. chabaudi (1). The two strains differed also in the immunity they induced
against the parasites pre-blood patency. Experiments testing whether strains such as CB induce pan-strain immunity through broader antigen repertoire and whether this is linked to lower parasite densities in control infections are now required. Quantifying variation in strain-specificity and explaining the underlying mechanisms are central to predicting the success of interventions that work by inducing immunity. It is conceivable that differences in the viabilities of CB and AJ sporozoites may have contributed to some of the effects observed in this study, as this would result in the development of differing numbers of exo-erythrocytic stage parasites for each strain during the immunization procedure. However, we found no evidence for any differences in viabilities when assessing sporozoite motility prior to inoculation.
Type II cytokines (IL-4 and IL-13), in particular IL-4, have been reported to have a critical role in the initiation of DSS-induced colitis[5,
7, 28] and we found, above, that IL-33 can induce serum type II cytokines in mice with colitis (Fig. 3). To define the requirement of IL-4 in colitis exacerbation and type II cytokine induction by IL-33, IL-4−/− mice were given the same treatments of PBS, IL-33, DSS or DSS plus IL-33 as described Epigenetics Compound Library research buy in Fig. 2. As reported, IL-4−/− mice that received DSS to induce colitis showed a delayed appearance of diarrhoea on day 10 and had attenuated pathogenic changes in the colon compared with WT mice (Fig. 4a,b). More importantly, similar to ST2−/− mice, IL-33 failed to exacerbate these clinical and pathological parameters of colitis in the IL-4−/− mice. Compared with WT controls, changes in colon length and histological score associated with administration of IL-33 were also not apparent in IL-4−/− mice (Fig. 4b). In addition, IL-4 deficiency check details abolished the production of IL-13, IL-12, CXCL9 and VEGF in the IL-33-treated group, IL-12 and VEGF in the DSS-treated group and IL-5, IL-13, IL-12, CXCL9 and VEGF in the DSS plus IL-33-treated
group compared with cytokine and chemokine induction in similarly treated WT mice on day 20 (Fig. 4c). However, the serum concentrations of IL-10 were not affected by IL-4 deficiency. We further investigated
the importance of IL-4 receptor (IL-4R) in the context, which is required for both IL-4 and IL-13 signalling. We found that similar to ST2−/− and IL-4−/− mice, the shortened colon lengths in DSS or DSS plus IL-33 treated WT mice were also prevented in the groups of similarly treated IL-4R−/− mice (see Supplementary material, Fig. S3A). The reduced colon pathogenic change was accompanied by reduced IFN-γ and TNF-α, but enhanced IL-4 and IL-13 production in colon cultures in IL-4R−/− mice groups compared with the groups of similarly treated WT mice (Fig. S3B). The enhanced oxyclozanide IL-4 and IL-13 may be a result of the loss of consumption of these cytokines in the IL-4R−/− mice tissues. Therefore, these results suggest that IL-33 exacerbates colitis primarily via IL-4. Data reported in this comprehensive study reveal a hitherto unrecognized effect and mechanism by which the IL-33/ST2 axis exacerbates DSS-induced colitis. Increasing evidence suggests that the development of UC may be attributed to intestinal epithelial barrier dysfunction and abnormal angiogenesis.
Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by chronic inflammation of the joints. Previously, several independent groups have explored the therapeutic effects of MSCs in a collagen-induced arthritis (CIA) model, and generated conflicting results [19–22]. Augello et al. reported that MSC treatment decreased the serum concentration of tumour necrosis factor (TNF)-α and alleviated CIA by educating
regulatory T cells (Tregs) Roscovitine research buy , but Djouad et al. found that the addition of TNF-α to in vitro co-culture of MSCs and lymphocytes reversed the proliferation-suppressive properties of MSCs, and proposed that the presence of TNF-α in CIA animals led to aggravation of the disease after MSC treatment . Indeed, there is some evidence showing that MSCs may up-regulate the immune response [23–25]. The underlying reasons for the
discrepancy are currently unknown. MSCs are heterogeneous cells without a defined phenotype and are always cultured using different Selleckchem Small molecule library modified methods by different laboratories. The difference in cells may account at least partly for the conflicting results in animal studies. Moreover, the circumstances in CIA animals are much more complicated than in vitro culture: the phenomena observed in cultured cells may not happen exactly as in animal models. To clarify this issue, it is important to investigate the therapeutic effect with a defined MSC population and explore the underlying mechanisms in vivo. We have been engaged in the studies of Flk-1+ MSCs for a long time. They are a MSC subpopulation
with a defined phenotype. We have completed Phase I clinical trials and have shown that Flk-1+ MSCs are safe and effective in the treatment of GVHD ; Phase II clinical trials for GVHD are on the way. In this study, we investigated the therapeutic effect of Flk-1+ MSCs on CIA mice. Considering the present application of Flk-1+ MSCs in clinical trials, this study is of great importance for the establishment of inclusion criteria in enrolling potential candidates. Flk-1+ MSCs were isolated from bone marrow of dilute brown non-Agouti (DBA-1) mice and cultured as we have described previously [1,3]. Briefly, mononuclear cells were obtained Decitabine supplier by Ficoll-Paque density gradient centrifugation from bone marrow flushes, depleted of haematopoietic cells, and cultured in Dulbecco modified Eagle medium and Ham F12 medium (DF12) culture medium containing 40% MCDB-201 medium complete with trace elements (MCDB) medium (Sigma, St Louis, MO, USA), 2% fetal bovine serum (FBS), 10 ng/ml epidermal growth factor, 10 ng/ml platelet-derived growth factor BB, insulin transferring selenium, linoleic acid and bovine serum albumin (BSA) at 37°C and 5% CO2. The non-adherent cell population was removed after 24–48 h and the adherent layer was cultured for approximately 1 week. When cells reached 90% confluence they were harvested by trypsinization (0·25% trypsin).
The initial rate of haemoglobin digestion peaked at pH 4·0. Above pH 6·0, the rate was no different to controls, which correlated with gel analysis of the 24-h reaction samples; revealing that the 15-kDa haemoglobin doublet was depleted up to pH 6·1 compared to controls (Figure 2). For reactions with albumin a very similar profile was generated, with the fastest initial rate of digestion observed at pH 3·7 (Figure 3). However, the initial rate values obtained were selleckchem approximately fivefold lower than those for the digestion of haemoglobin and consequently much closer to background control values. SDS PAGE analysis confirmed that there was a decrease in the intensity
of intact albumin, accompanied by an increase in lower molecular weight bands presumed to be partially digested albumin, below pH 5·6. It can also be seen that below pH 4·2, albumin digestion occurred in the absence of H-gal-GP, presumably as a result of the acidic conditions Selleckchem PD98059 (Figure 3). Similarly for haemoglobin digestion, the doublet in the 24-h samples corresponding to haemoglobin shows decreased intensity compared to corresponding 0-h samples for enzyme-free controls as well as for reactions containing H-gal-GP at pH conditions below pH 4·2 (Figure 2). Reactions
of H-gal-GP with different concentrations of ovine haemoglobin substrate at pH 5·0 were set up and the increase in free amino groups was monitored by taking samples at regular time intervals. It was assumed that the absorbance value obtained after a 24-h digestion represented a complete turnover of all haemoglobin in the reaction and therefore
was equivalent to the total concentration of haemoglobin in the reaction. The absorbance value of each sample from all time points was used to estimate its concentration of haemoglobin. These concentration estimates were then plotted against time to obtain a turnover rate per second (v). This rate was plotted against the total concentration of haemoglobin in the reaction to produce the Michaelis–Menton curve which gave a kcat of 0·03 s−1 and a KM of 29 μm (Figure 4). The rate of digestion of ovine haemoglobin was monitored Cetuximab in vitro as before except that the H-gal-GP was pre-incubated with serum IgG obtained from sheep which had been successfully vaccinated with H-gal-GP (pIgG – see Table 1) or from control sheep immunized with adjuvant alone (cIgG – see Table 1). Different pH conditions under which IgG bound to H-gal-GP (with pre-incubation at pH 7·4 followed by reaction at pH 4·0 and with pre-incubation and reaction both at pH 4·0 as described in the Materials and Methods) were tested before the detection of IgG inhibition at pH 5·0 (data not shown). For inhibition experiments carried out with both the IgG pre-incubation and subsequent reactions held at pH 5·0, H-gal-GP was incubated with either pA, pIgG, cIgG or buffer.
Mucosal leishmaniasis (ML), a severe chronic disease caused by leishmania protozoa, remains a serious health problem in several parts of the world, including Brazil 1. ML is at the hyper-responsive end of the spectrum of clinical diseases caused by Leishmania braziliensis1. Uncontrolled immune responses have been implicated in ML pathogenesis because T lymphocytes from ML patients initiate intense responses (characterised by lymphoproliferation
and cytokine production) despite the low number of parasites in mucosal lesions 2–4. In addition to Th1 cytokines, TGF-β and IL-6 are also produced in ML lesions, but the significance of this finding is poorly understood 5. Th17 cells participate RO4929097 solubility dmso in
inflammatory responses to several human infectious agents 6, 7. IL-17, the Th17 signature cytokine, induces tissue damage mediated by neutrophil attraction and proteinase release. Neutrophil recruitment mediated by IL-17+ cells contributes to disease progression in susceptible mouse strains infected with L. major8. Although the cytokine combination that leads to human Th17 differentiation and maintenance remains controversial, TGF-β and IL-6, along with IL-23 and IL-1β, have been implicated in this phenomenon 9, 10. Recently in human ML, IL-17 expression has been detected 11, but the cell source of this expression has not yet been determined. In this study, we expand on the observations reported by Bacellar et al. 11 by demonstrating that in addition to Th17 cells, CD8+ and CD14+ cells express IL-17. We also this website detected the presence of neutrophils expressing proteinases in tissue-damaged areas, suggesting a potential function for Th17 cells in ML lesions. IL-17 expression was consistently higher in ML lesions (n=12) than in normal mucosal samples
(n=4), as shown in Fig. 1A and B. Marked expression was detected in mononuclear cells, endothelial cells and perivascular fusiform cells. No reactivity was detected using an isotype control antibody (Fig. 1G). As for Atorvastatin cytokines involved in IL-17 production, ML lesions presented an intense expression of both TGF-β, which is found in mononuclear cell aggregates and in endothelial cells disseminated throughout the inflammatory infiltrate (Fig. 1C), and IL-1β, which is detected mainly in mononuclear cells near the ulcer in the inflammatory infiltrate (Fig. 1D). IL-23 was heterogeneously distributed in ML patients, alternating between intense signals in mononuclear cells in some tissue samples (Fig. 1E) and only slight reactivity in other specimens. Weak IL-6 staining was occasionally observed in mononuclear cells located at periglandular areas and in blood vessels dispersed in the inflammatory infiltrate (Fig. 1F). Cytokine quantification analyses revealed higher expression of all cytokines in ML lesions than in normal mucosal tissue samples (Fig. 1H).